AbCellera
also invests Β· investor profileFounded 2012 Β· 2 known investors
AbCellera develops antibody-based medicines using a technology platform that integrates biology, computation, and engineering, working with pharmaceutical partners on antibody drug programs including bispecifics and antibody drug conjugates. The company operates in the biotech and drug discovery sector, focusing on first-in-class and best-in-class antibody therapeutics for complex targets such as transmembrane proteins.
AI & Machine LearningBiotechDeep Tech
Investors Β· 2
Frequently asked questions
- What does AbCellera do?
- AbCellera develops antibody-based medicines using a technology platform that integrates biology, computation, and engineering, working with pharmaceutical partners on antibody drug programs including bispecifics and antibody drug conjugates. The company operates in the biotech and drug discovery sector, focusing on first-in-class and best-in-class antibody therapeutics for complex targets such as transmembrane proteins.
- Who are AbCellera's investors?
- AbCellera's investors include Alpha Wave Global, DCVC (Data Collective).